| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.38e-06 | 188 | 38 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | integrin binding | 1.94e-05 | 175 | 38 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 7.82e-05 | 120 | 38 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.19e-04 | 599 | 38 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.47e-04 | 268 | 38 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 2.30e-04 | 12 | 38 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 3.16e-04 | 14 | 38 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | heparin binding | 4.74e-04 | 192 | 38 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 5.52e-04 | 200 | 38 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.70e-03 | 749 | 38 | 6 | GO:0005509 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.98e-05 | 4 | 38 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 9.19e-05 | 8 | 38 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.50e-04 | 445 | 38 | 6 | GO:0141091 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 1.80e-04 | 11 | 38 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 2.31e-04 | 482 | 38 | 6 | GO:0007178 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 2.55e-04 | 13 | 38 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 2.55e-04 | 13 | 38 | 2 | GO:1900116 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS16 LAMA3 ADAMTS18 CCN4 LTBP2 FBN1 FBN2 ZAN EDIL3 LTBP4 | 2.42e-07 | 656 | 39 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS16 LAMA3 ADAMTS18 CCN4 LTBP2 FBN1 FBN2 ZAN EDIL3 LTBP4 | 2.48e-07 | 658 | 39 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | microfibril | 1.70e-06 | 13 | 39 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.14e-04 | 530 | 39 | 6 | GO:0062023 | |
| HumanPheno | Abnormal upper to lower segment ratio | 3.95e-05 | 3 | 19 | 2 | HP:0012772 | |
| HumanPheno | Microspherophakia | 7.87e-05 | 4 | 19 | 2 | HP:0030961 | |
| HumanPheno | Iridodonesis | 1.31e-04 | 5 | 19 | 2 | HP:0100693 | |
| HumanPheno | Spherophakia | 1.31e-04 | 5 | 19 | 2 | HP:0034375 | |
| MousePheno | overexpanded pulmonary alveolus | 2.30e-06 | 37 | 36 | 4 | MP:0001183 | |
| Domain | EGF | SCARF1 TENM1 LAMA3 LTBP2 FBN1 FBN2 ZAN EGFL8 EDIL3 LTBP4 ADAM22 | 8.83e-13 | 235 | 38 | 11 | SM00181 |
| Domain | EGF-like_dom | SCARF1 TENM1 LAMA3 LTBP2 FBN1 FBN2 ZAN EGFL8 EDIL3 LTBP4 ADAM22 | 1.66e-12 | 249 | 38 | 11 | IPR000742 |
| Domain | EGF_1 | SCARF1 TENM1 LAMA3 LTBP2 FBN1 FBN2 ZAN EGFL8 EDIL3 LTBP4 ADAM22 | 2.15e-12 | 255 | 38 | 11 | PS00022 |
| Domain | EGF-like_CS | SCARF1 TENM1 LAMA3 LTBP2 FBN1 FBN2 ZAN EGFL8 EDIL3 LTBP4 ADAM22 | 2.77e-12 | 261 | 38 | 11 | IPR013032 |
| Domain | EGF_2 | SCARF1 TENM1 LAMA3 LTBP2 FBN1 FBN2 ZAN EGFL8 EDIL3 LTBP4 ADAM22 | 3.27e-12 | 265 | 38 | 11 | PS01186 |
| Domain | EGF_3 | 2.85e-11 | 235 | 38 | 10 | PS50026 | |
| Domain | TB | 5.07e-10 | 7 | 38 | 4 | PF00683 | |
| Domain | - | 1.01e-09 | 8 | 38 | 4 | 3.90.290.10 | |
| Domain | TB | 1.82e-09 | 9 | 38 | 4 | PS51364 | |
| Domain | TB_dom | 1.82e-09 | 9 | 38 | 4 | IPR017878 | |
| Domain | Growth_fac_rcpt_ | 2.52e-08 | 156 | 38 | 7 | IPR009030 | |
| Domain | EGF_Ca-bd_CS | 4.05e-08 | 97 | 38 | 6 | IPR018097 | |
| Domain | EGF_CA | 4.58e-08 | 99 | 38 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.87e-08 | 100 | 38 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.90e-08 | 106 | 38 | 6 | IPR000152 | |
| Domain | EGF_extracell | 1.34e-07 | 60 | 38 | 5 | IPR013111 | |
| Domain | EGF_2 | 1.34e-07 | 60 | 38 | 5 | PF07974 | |
| Domain | EGF_CA | 1.60e-07 | 122 | 38 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.76e-07 | 124 | 38 | 6 | IPR001881 | |
| Domain | EGF_CA | 8.20e-07 | 86 | 38 | 5 | PF07645 | |
| Domain | FBN | 1.21e-05 | 3 | 38 | 2 | IPR011398 | |
| Domain | Peptidase_M12B_N | 6.75e-05 | 39 | 38 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 6.75e-05 | 39 | 38 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 7.29e-05 | 40 | 38 | 3 | PS00427 | |
| Domain | ADAM_MEPRO | 7.29e-05 | 40 | 38 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 7.29e-05 | 40 | 38 | 3 | PS50214 | |
| Domain | Reprolysin | 7.29e-05 | 40 | 38 | 3 | PF01421 | |
| Domain | Peptidase_M12B | 7.29e-05 | 40 | 38 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 7.85e-05 | 41 | 38 | 3 | IPR001762 | |
| Domain | EGF | 1.22e-04 | 126 | 38 | 4 | PF00008 | |
| Domain | TSP_1 | 2.84e-04 | 63 | 38 | 3 | PF00090 | |
| Domain | NHL | 3.10e-04 | 13 | 38 | 2 | PS51125 | |
| Domain | TSP1 | 3.11e-04 | 65 | 38 | 3 | SM00209 | |
| Domain | TSP1_rpt | 3.11e-04 | 65 | 38 | 3 | IPR000884 | |
| Domain | TSP1 | 3.11e-04 | 65 | 38 | 3 | PS50092 | |
| Domain | PLAC | 3.61e-04 | 14 | 38 | 2 | PF08686 | |
| Domain | MetalloPept_cat_dom | 5.94e-04 | 81 | 38 | 3 | IPR024079 | |
| Domain | - | 5.94e-04 | 81 | 38 | 3 | 3.40.390.10 | |
| Domain | PLAC | 6.74e-04 | 19 | 38 | 2 | IPR010909 | |
| Domain | PLAC | 6.74e-04 | 19 | 38 | 2 | PS50900 | |
| Domain | ADAM_spacer1 | 9.93e-04 | 23 | 38 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 9.93e-04 | 23 | 38 | 2 | PF05986 | |
| Domain | ZINC_PROTEASE | 1.03e-03 | 98 | 38 | 3 | PS00142 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.08e-03 | 24 | 38 | 2 | IPR013273 | |
| Domain | cEGF | 1.27e-03 | 26 | 38 | 2 | IPR026823 | |
| Domain | cEGF | 1.27e-03 | 26 | 38 | 2 | PF12662 | |
| Domain | hEGF | 1.47e-03 | 28 | 38 | 2 | PF12661 | |
| Domain | Laminin_EGF | 2.30e-03 | 35 | 38 | 2 | PF00053 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.30e-03 | 35 | 38 | 2 | IPR002464 | |
| Domain | VWFC_1 | 2.43e-03 | 36 | 38 | 2 | PS01208 | |
| Domain | VWC | 2.71e-03 | 38 | 38 | 2 | SM00214 | |
| Domain | Laminin_EGF | 2.71e-03 | 38 | 38 | 2 | IPR002049 | |
| Domain | DEAH_ATP_HELICASE | 2.71e-03 | 38 | 38 | 2 | PS00690 | |
| Domain | VWFC_2 | 2.71e-03 | 38 | 38 | 2 | PS50184 | |
| Domain | - | 2.85e-03 | 39 | 38 | 2 | 2.120.10.30 | |
| Domain | CYSTEINE_SWITCH | 3.14e-03 | 41 | 38 | 2 | PS00546 | |
| Domain | VWF_dom | 3.30e-03 | 42 | 38 | 2 | IPR001007 | |
| Domain | Pept_M10_metallopeptidase | 3.45e-03 | 43 | 38 | 2 | IPR001818 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.94e-03 | 46 | 38 | 2 | IPR011042 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.42e-08 | 300 | 23 | 8 | M610 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 7.57e-08 | 140 | 23 | 6 | M587 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.88e-07 | 32 | 23 | 4 | MM14854 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.43e-07 | 37 | 23 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.26e-07 | 39 | 23 | 4 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.00e-07 | 44 | 23 | 4 | M26969 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 8.52e-06 | 25 | 23 | 3 | M39713 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.08e-05 | 38 | 23 | 3 | MM14874 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.07e-05 | 258 | 23 | 5 | MM14572 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 5.87e-05 | 47 | 23 | 3 | M646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 7.09e-05 | 8 | 23 | 2 | M47850 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.57e-04 | 77 | 23 | 3 | MM14670 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 3.41e-04 | 17 | 23 | 2 | M212 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 4.62e-04 | 94 | 23 | 3 | M1041 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.11e-04 | 114 | 23 | 3 | MM14571 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 8.96e-04 | 118 | 23 | 3 | MM15588 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.82e-03 | 39 | 23 | 2 | MM15165 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.82e-03 | 39 | 23 | 2 | M27417 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.19e-03 | 161 | 23 | 3 | M27871 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.21e-03 | 43 | 23 | 2 | M53 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.13e-03 | 66 | 23 | 2 | M18 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.43e-03 | 68 | 23 | 2 | M27303 | |
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 12429738 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.98e-08 | 26 | 39 | 4 | 34189436 | |
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 8.68e-08 | 37 | 39 | 4 | 34323105 | |
| Pubmed | 6.25e-07 | 146 | 39 | 5 | 27068509 | ||
| Pubmed | 7.23e-07 | 16 | 39 | 3 | 30579834 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 1.05e-06 | 18 | 39 | 3 | 39040056 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 12399449 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 28252045 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 21851253 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 12429739 | ||
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 1.23e-06 | 2 | 39 | 2 | 24833718 | |
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 1.23e-06 | 2 | 39 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 1.23e-06 | 2 | 39 | 2 | 21440062 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 15131124 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 24265020 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 1.23e-06 | 2 | 39 | 2 | 12524050 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20529844 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 1.23e-06 | 2 | 39 | 2 | 25524144 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 1.23e-06 | 2 | 39 | 2 | 20404337 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 23133647 | ||
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 1.23e-06 | 2 | 39 | 2 | 8791520 | |
| Pubmed | Evaluation of ADAMTS12, ADAMTS16, ADAMTS18 and IL-33 serum levels in pre-eclampsia. | 1.23e-06 | 2 | 39 | 2 | 26382559 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 8120105 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 35419902 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 24867584 | ||
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 1.23e-06 | 2 | 39 | 2 | 8307578 | |
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 1.23e-06 | 2 | 39 | 2 | 16407178 | |
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 1.23e-06 | 2 | 39 | 2 | 10504303 | |
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 1.23e-06 | 2 | 39 | 2 | 1852206 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 10359653 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 1.23e-06 | 2 | 39 | 2 | 7744963 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 1.23e-06 | 2 | 39 | 2 | 18006876 | |
| Pubmed | 1.53e-06 | 175 | 39 | 5 | 28071719 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.68e-06 | 86 | 39 | 4 | 28327460 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 10825173 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 17293099 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 30201140 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 20855508 | ||
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 5.18e-06 | 30 | 39 | 3 | 32882513 | |
| Pubmed | Human eye development is characterized by coordinated expression of fibrillin isoforms. | 7.34e-06 | 4 | 39 | 2 | 25406291 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 21540769 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 15611103 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 20729550 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 7.34e-06 | 4 | 39 | 2 | 25034023 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 16507336 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 7.34e-06 | 4 | 39 | 2 | 11104663 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 16835936 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 20301293 | ||
| Pubmed | Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. | 8.32e-06 | 35 | 39 | 3 | 19862010 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 26601954 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 17255108 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 34411563 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 12590922 | ||
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 1.22e-05 | 5 | 39 | 2 | 23493297 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 19349279 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 19182256 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 7873879 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 10848613 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 11867212 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 10930463 | ||
| Pubmed | Regulation of limb patterning by extracellular microfibrils. | 2.56e-05 | 7 | 39 | 2 | 11470817 | |
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 3.42e-05 | 8 | 39 | 2 | 23055981 | |
| Pubmed | Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway. | 3.42e-05 | 8 | 39 | 2 | 31201465 | |
| Pubmed | Targeting of bone morphogenetic protein growth factor complexes to fibrillin. | 3.42e-05 | 8 | 39 | 2 | 18339631 | |
| Pubmed | 3.70e-05 | 167 | 39 | 4 | 22159717 | ||
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 12122015 | ||
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 38844137 | ||
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 30738849 | ||
| Pubmed | 7.07e-05 | 71 | 39 | 3 | 33541421 | ||
| Pubmed | 8.03e-05 | 12 | 39 | 2 | 26405179 | ||
| Pubmed | 8.03e-05 | 12 | 39 | 2 | 36779913 | ||
| Pubmed | 8.32e-05 | 75 | 39 | 3 | 20637190 | ||
| Pubmed | 9.81e-05 | 674 | 39 | 6 | 37196079 | ||
| Pubmed | 1.11e-04 | 14 | 39 | 2 | 31242448 | ||
| Pubmed | 1.27e-04 | 15 | 39 | 2 | 7543410 | ||
| Pubmed | 1.65e-04 | 17 | 39 | 2 | 25263278 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.71e-04 | 248 | 39 | 4 | 24006456 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.79e-04 | 97 | 39 | 3 | 27559042 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 1.85e-04 | 18 | 39 | 2 | 35503090 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 2.01e-04 | 101 | 39 | 3 | 20551380 | |
| Pubmed | 3.62e-04 | 25 | 39 | 2 | 21518438 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.72e-04 | 135 | 39 | 3 | 28675934 | |
| Pubmed | 5.23e-04 | 30 | 39 | 2 | 20301299 | ||
| Pubmed | 5.58e-04 | 143 | 39 | 3 | 20424473 | ||
| Pubmed | 5.58e-04 | 31 | 39 | 2 | 25762570 | ||
| Pubmed | 7.54e-04 | 36 | 39 | 2 | 35167946 | ||
| Pubmed | 7.54e-04 | 36 | 39 | 2 | 20587546 | ||
| Pubmed | 9.30e-04 | 40 | 39 | 2 | 30578393 | ||
| Interaction | NTN5 interactions | 1.32e-05 | 24 | 39 | 3 | int:NTN5 | |
| Interaction | ADAMTS19 interactions | 3.64e-05 | 5 | 39 | 2 | int:ADAMTS19 | |
| Interaction | FBXO2 interactions | 1.28e-04 | 411 | 39 | 6 | int:FBXO2 | |
| Interaction | MFAP5 interactions | 1.39e-04 | 52 | 39 | 3 | int:MFAP5 | |
| Interaction | ZNF408 interactions | 1.74e-04 | 145 | 39 | 4 | int:ZNF408 | |
| Interaction | ZFP41 interactions | 1.82e-04 | 57 | 39 | 3 | int:ZFP41 | |
| Interaction | MFAP2 interactions | 2.38e-04 | 12 | 39 | 2 | int:MFAP2 | |
| Interaction | HRG interactions | 2.46e-04 | 63 | 39 | 3 | int:HRG | |
| Interaction | FBN2 interactions | 2.69e-04 | 65 | 39 | 3 | int:FBN2 | |
| Cytoband | Xq25 | 5.65e-04 | 41 | 39 | 2 | Xq25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq26 | 9.34e-03 | 171 | 39 | 2 | chrXq26 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.29e-05 | 4 | 27 | 2 | 628 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.62e-04 | 19 | 27 | 2 | 50 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.23e-08 | 191 | 39 | 7 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.47e-08 | 196 | 39 | 7 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 1.32e-07 | 270 | 39 | 7 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.50e-07 | 275 | 39 | 7 | M5884 | |
| Coexpression | NABA_MATRISOME | ADAMTS16 LAMA3 ADAMTS18 CCN4 LTBP2 FBN1 FBN2 EGFL8 EDIL3 LTBP4 ADAM22 | 1.61e-07 | 1008 | 39 | 11 | MM17056 |
| Coexpression | NABA_MATRISOME | ADAMTS16 LAMA3 ADAMTS18 CCN4 LTBP2 FBN1 FBN2 EGFL8 EDIL3 LTBP4 ADAM22 | 1.92e-07 | 1026 | 39 | 11 | M5889 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 8.28e-05 | 493 | 39 | 6 | M1951 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 9.34e-05 | 504 | 39 | 6 | MM830 | |
| Coexpression | TGFB_UP.V1_UP | 1.77e-04 | 189 | 39 | 4 | M2839 | |
| Coexpression | GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 2.20e-04 | 200 | 39 | 4 | M7777 | |
| Coexpression | GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN | 2.20e-04 | 200 | 39 | 4 | M9665 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.20e-04 | 200 | 39 | 4 | M5930 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.42e-07 | 183 | 39 | 5 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 5.57e-07 | 184 | 39 | 5 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.72e-07 | 185 | 39 | 5 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-07 | 188 | 39 | 5 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 6.36e-07 | 189 | 39 | 5 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.87e-07 | 192 | 39 | 5 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.87e-07 | 192 | 39 | 5 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.87e-07 | 192 | 39 | 5 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.05e-07 | 193 | 39 | 5 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 7.80e-07 | 197 | 39 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.80e-07 | 197 | 39 | 5 | 2e3d64648a1e4f01b9256a96b94b8a640ee1824c | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 8.00e-07 | 198 | 39 | 5 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.20e-07 | 199 | 39 | 5 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.41e-07 | 200 | 39 | 5 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-05 | 160 | 39 | 4 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-05 | 160 | 39 | 4 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-05 | 169 | 39 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.53e-05 | 172 | 39 | 4 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.56e-05 | 173 | 39 | 4 | b0ff9808e38cb64a734ced498cd0546728746cd5 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 173 | 39 | 4 | 295bfe1efa648173c2d5981025bc61c576baf53f | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-05 | 174 | 39 | 4 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 175 | 39 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 175 | 39 | 4 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 179 | 39 | 4 | c7c74e26bbf86c5326ee38bac7de111d5414f46b | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-05 | 180 | 39 | 4 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-05 | 180 | 39 | 4 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.87e-05 | 181 | 39 | 4 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 181 | 39 | 4 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 181 | 39 | 4 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-05 | 183 | 39 | 4 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 183 | 39 | 4 | 7e5c467fd1b156b928f1611a12ab4affb9f714b7 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-05 | 183 | 39 | 4 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-05 | 183 | 39 | 4 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 183 | 39 | 4 | 63294d66e3ccf152ffe5d1237106764c14390b62 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 184 | 39 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 184 | 39 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 184 | 39 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 185 | 39 | 4 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.08e-05 | 186 | 39 | 4 | c0a036096c2cb23305605b8aaf18869d6e0fb512 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 186 | 39 | 4 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 186 | 39 | 4 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-05 | 186 | 39 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.12e-05 | 187 | 39 | 4 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.12e-05 | 187 | 39 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.12e-05 | 187 | 39 | 4 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-05 | 188 | 39 | 4 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 189 | 39 | 4 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 189 | 39 | 4 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-05 | 189 | 39 | 4 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-05 | 190 | 39 | 4 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 190 | 39 | 4 | d13fd234caa3fc69d8a59bc0060cdacdf716ee55 | |
| ToppCell | P07|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.26e-05 | 190 | 39 | 4 | 38a613a9bca0ba040c3ada00286d1ce6f83ab23a | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.30e-05 | 191 | 39 | 4 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-05 | 191 | 39 | 4 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 191 | 39 | 4 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-05 | 191 | 39 | 4 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.30e-05 | 191 | 39 | 4 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.30e-05 | 191 | 39 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.30e-05 | 191 | 39 | 4 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.30e-05 | 191 | 39 | 4 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 191 | 39 | 4 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 193 | 39 | 4 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 193 | 39 | 4 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 194 | 39 | 4 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 194 | 39 | 4 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 194 | 39 | 4 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 2.50e-05 | 195 | 39 | 4 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.55e-05 | 196 | 39 | 4 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 196 | 39 | 4 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-05 | 197 | 39 | 4 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.60e-05 | 197 | 39 | 4 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 197 | 39 | 4 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.60e-05 | 197 | 39 | 4 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-05 | 197 | 39 | 4 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.60e-05 | 197 | 39 | 4 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-05 | 198 | 39 | 4 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-05 | 198 | 39 | 4 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.65e-05 | 198 | 39 | 4 | 4a4566f86c9365a41b4cfd1609eac09bd73b3f34 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-05 | 198 | 39 | 4 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-05 | 198 | 39 | 4 | 7d2fe57e0f9311ac1e6854402ebc154306eb1ba5 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-05 | 199 | 39 | 4 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 199 | 39 | 4 | 30ab0750d51f168b18c434c974d24a4e70f29cc7 | |
| ToppCell | distal-mesenchymal-Myofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.71e-05 | 199 | 39 | 4 | 79917b5225cb45b4a0ea937f79f1752346e4346e | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.71e-05 | 199 | 39 | 4 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 199 | 39 | 4 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 2.71e-05 | 199 | 39 | 4 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.71e-05 | 199 | 39 | 4 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.71e-05 | 199 | 39 | 4 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.71e-05 | 199 | 39 | 4 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 199 | 39 | 4 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.71e-05 | 199 | 39 | 4 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 199 | 39 | 4 | 137ff58897e6ada8a5a70205f66fe9110795506b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-05 | 199 | 39 | 4 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.71e-05 | 199 | 39 | 4 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.71e-05 | 199 | 39 | 4 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.76e-05 | 200 | 39 | 4 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | 2.76e-05 | 200 | 39 | 4 | bb605b373caf3f873dc1b87d712704568e0d6040 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.76e-05 | 200 | 39 | 4 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-05 | 200 | 39 | 4 | 3e6730c9ed7003a4acf501f699a4965a7a50f946 | |
| Drug | funiferine N-oxide | 1.47e-06 | 49 | 39 | 4 | CID000191631 | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.04e-05 | 196 | 39 | 5 | 3705_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.04e-05 | 196 | 39 | 5 | 3847_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 4358_UP | |
| Disease | connective tissue disease (implicated_via_orthology) | 4.84e-06 | 3 | 38 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 4.84e-06 | 3 | 38 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 4.84e-06 | 3 | 38 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 4.84e-06 | 3 | 38 | 2 | C1869114 | |
| Disease | Weill-Marchesani syndrome | 9.67e-06 | 4 | 38 | 2 | cv:C0265313 | |
| Disease | scoliosis (is_implicated_in) | 9.67e-06 | 4 | 38 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 9.67e-06 | 4 | 38 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Marfan Syndrome | 8.82e-05 | 11 | 38 | 2 | C0024796 | |
| Disease | ferritin measurement | 4.87e-04 | 119 | 38 | 3 | EFO_0004459 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to cold medicine | 1.05e-03 | 37 | 38 | 2 | EFO_0004276, EFO_0004775, EFO_0006997 | |
| Disease | Lymphoma | 1.22e-03 | 40 | 38 | 2 | C0024299 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EAICAKPCLNGGVCV | 111 | Q99944 | |
| CEVCQQGGEIILCDT | 346 | Q8TDI0 | |
| GTPAECVLEGAECCK | 461 | Q9P0K1 | |
| CIDGAVGCTPLCLRV | 146 | O95388 | |
| SINCCVGLCLVPGKL | 341 | Q8TF44 | |
| VCIDGICERVGCDNV | 711 | Q8TE57 | |
| KNDVCIDGVCELVGC | 711 | Q8TE60 | |
| CPVCDQKVVLAEAAG | 91 | Q2Q1W2 | |
| VCDPGTGACLCKENV | 1416 | Q16787 | |
| KLKCDICGIICIGPN | 116 | Q13422 | |
| CILPGVGTKVADCIC | 241 | O15527 | |
| ILCNLCGVVPGGVVC | 691 | Q96FC9 | |
| NECEVEPCKNGGICT | 121 | O43854 | |
| CCGLCNGVLIEETEI | 571 | Q8N6C5 | |
| VDECEKNPCAGGECI | 491 | P35555 | |
| GCKVLCCTPGGVVLI | 206 | Q96JQ5 | |
| VNECLTPGVCAHGKC | 1011 | Q14767 | |
| VLCPLICHNGGVCVK | 151 | Q8N2S1 | |
| VADVCPKEDSGGLCC | 496 | Q5VTJ3 | |
| ALAGCLLPAEGCVIC | 11 | Q8IYV9 | |
| ECKEIPGICANGVCI | 1811 | P35556 | |
| ISCDLIGCPLVCGAV | 26 | Q8TB52 | |
| CPGGESKCVVRVEEC | 101 | Q9HBV2 | |
| ALPLAECKEGLVCNG | 916 | Q13615 | |
| GTCPICKCDILKVLG | 291 | Q8WVZ7 | |
| VVCENGLPIKEGLSC | 731 | Q6ZUX3 | |
| CILKCEGTGVCVLTG | 501 | Q9BZQ2 | |
| EVGCVDPDVCQRICG | 346 | Q2M3M2 | |
| VCICVPGYKGEICEE | 611 | Q9UKZ4 | |
| ICEGPDACQKDEVCV | 56 | Q14162 | |
| KEGPLVHVACCCGNI | 281 | P51790 | |
| GDELCPAEQKCCTTG | 46 | Q8IUB2 | |
| HGNIVKNCCEVLCGP | 276 | Q9Y397 | |
| CLCAGAKPKLICEGN | 111 | Q8WU10 | |
| VEEEGLQICVEICGC | 346 | Q8IZM8 | |
| DGEVLKPQCIICGDV | 751 | Q6R2W3 | |
| LCKEQGITVVGICCV | 186 | Q6ZXV5 | |
| GDIPCICKECGKVFI | 331 | Q9Y473 | |
| VNGLCVPACDGVKDC | 466 | Q8IU80 | |
| EGAKVPSACAEGCIC | 2236 | Q9Y493 |